 | • レポートコード：MRC2Q12-17136 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、臨床LC-MSのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 臨床LC-MSのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 臨床LC-MSの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 臨床LC-MSのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの臨床LC-MSの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の臨床LC-MSの売上および2028年までの予測に焦点を当てています。 臨床LC-MSのグローバル主要企業には、Danaher、Bruker、Agilent、Thermo Fisher、Waters、Shidmazu、Perkin Elmer、Merck、BGIなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 臨床LC-MS市場は、タイプとアプリケーションによって区分されます。世界の臨床LC-MS市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 装置、試薬、消耗品、サービス 【アプリケーション別セグメント】 病院＆診療所、独立臨床検査室 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 臨床LC-MS製品概要 - タイプ別市場（装置、試薬、消耗品、サービス） - アプリケーション別市場（病院＆診療所、独立臨床検査室） - 調査の目的 ・エグゼクティブサマリー - 世界の臨床LC-MS販売量予測2017-2028 - 世界の臨床LC-MS売上予測2017-2028 - 臨床LC-MSの地域別販売量 - 臨床LC-MSの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別臨床LC-MS販売量 - 主要メーカー別臨床LC-MS売上 - 主要メーカー別臨床LC-MS価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（装置、試薬、消耗品、サービス） - 臨床LC-MSのタイプ別販売量 - 臨床LC-MSのタイプ別売上 - 臨床LC-MSのタイプ別価格 ・アプリケーション別市場規模（病院＆診療所、独立臨床検査室） - 臨床LC-MSのアプリケーション別販売量 - 臨床LC-MSのアプリケーション別売上 - 臨床LC-MSのアプリケーション別価格 ・北米市場 - 北米の臨床LC-MS市場規模（タイプ別、アプリケーション別） - 主要国別の臨床LC-MS市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの臨床LC-MS市場規模（タイプ別、アプリケーション別） - 主要国別の臨床LC-MS市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の臨床LC-MS市場規模（タイプ別、アプリケーション別） - 主要国別の臨床LC-MS市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の臨床LC-MS市場規模（タイプ別、アプリケーション別） - 主要国別の臨床LC-MS市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの臨床LC-MS市場規模（タイプ別、アプリケーション別） - 主要国別の臨床LC-MS市場規模（トルコ、サウジアラビア） ・企業情報 Danaher、Bruker、Agilent、Thermo Fisher、Waters、Shidmazu、Perkin Elmer、Merck、BGI ・産業チェーン及び販売チャネル分析 - 臨床LC-MSの産業チェーン分析 - 臨床LC-MSの原材料 - 臨床LC-MSの生産プロセス - 臨床LC-MSの販売及びマーケティング - 臨床LC-MSの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 臨床LC-MSの産業動向 - 臨床LC-MSのマーケットドライバー - 臨床LC-MSの課題 - 臨床LC-MSの阻害要因 ・主な調査結果 |
Liquid chromatography–mass spectrometry (LC–MS) is an analytical chemistry technique that combines the physical separation capabilities of liquid chromatography (or HPLC) with the mass analysis capabilities of mass spectrometry (MS).
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Clinical LC-MS estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Clinical LC-MS is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Clinical LC-MS is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Clinical LC-MS is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Clinical LC-MS include Danaher, Bruker, Agilent, Thermo Fisher, Waters, Shidmazu, Perkin Elmer, Merck and BGI, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Clinical LC-MS companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Clinical LC-MS market. Further, it explains the major drivers and regional dynamics of the global Clinical LC-MS market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Danaher
Bruker
Agilent
Thermo Fisher
Waters
Shidmazu
Perkin Elmer
Merck
BGI
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Clinical LC-MS Segment by Type
Device
Reagent
Consumables
Services
Clinical LC-MS Segment by Application
Hospital and Clinic
Independent Clinical Laboratory
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Clinical LC-MS market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Clinical LC-MS market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Clinical LC-MS, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Clinical LC-MS, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Clinical LC-MS revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Clinical LC-MS market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Clinical LC-MS revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Danaher, Bruker, Agilent, Thermo Fisher, Waters, Shidmazu, Perkin Elmer, Merck and BGI, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Clinical LC-MS in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical LC-MS companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical LC-MS revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical LC-MS Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Device
1.2.3 Reagent
1.2.4 Consumables
1.2.5 Services
1.3 Market by Application
1.3.1 Global Clinical LC-MS Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital and Clinic
1.3.3 Independent Clinical Laboratory
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Clinical LC-MS Market Perspective (2017-2028)
2.2 Clinical LC-MS Growth Trends by Region
2.2.1 Clinical LC-MS Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Clinical LC-MS Historic Market Size by Region (2017-2022)
2.2.3 Clinical LC-MS Forecasted Market Size by Region (2023-2028)
2.3 Clinical LC-MS Market Dynamics
2.3.1 Clinical LC-MS Industry Trends
2.3.2 Clinical LC-MS Market Drivers
2.3.3 Clinical LC-MS Market Challenges
2.3.4 Clinical LC-MS Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical LC-MS Players by Revenue
3.1.1 Global Top Clinical LC-MS Players by Revenue (2017-2022)
3.1.2 Global Clinical LC-MS Revenue Market Share by Players (2017-2022)
3.2 Global Clinical LC-MS Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical LC-MS Revenue
3.4 Global Clinical LC-MS Market Concentration Ratio
3.4.1 Global Clinical LC-MS Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical LC-MS Revenue in 2021
3.5 Clinical LC-MS Key Players Head office and Area Served
3.6 Key Players Clinical LC-MS Product Solution and Service
3.7 Date of Enter into Clinical LC-MS Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical LC-MS Breakdown Data by Type
4.1 Global Clinical LC-MS Historic Market Size by Type (2017-2022)
4.2 Global Clinical LC-MS Forecasted Market Size by Type (2023-2028)
5 Clinical LC-MS Breakdown Data by Application
5.1 Global Clinical LC-MS Historic Market Size by Application (2017-2022)
5.2 Global Clinical LC-MS Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Clinical LC-MS Market Size (2017-2028)
6.2 North America Clinical LC-MS Market Size by Type
6.2.1 North America Clinical LC-MS Market Size by Type (2017-2022)
6.2.2 North America Clinical LC-MS Market Size by Type (2023-2028)
6.2.3 North America Clinical LC-MS Market Share by Type (2017-2028)
6.3 North America Clinical LC-MS Market Size by Application
6.3.1 North America Clinical LC-MS Market Size by Application (2017-2022)
6.3.2 North America Clinical LC-MS Market Size by Application (2023-2028)
6.3.3 North America Clinical LC-MS Market Share by Application (2017-2028)
6.4 North America Clinical LC-MS Market Size by Country
6.4.1 North America Clinical LC-MS Market Size by Country (2017-2022)
6.4.2 North America Clinical LC-MS Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Clinical LC-MS Market Size (2017-2028)
7.2 Europe Clinical LC-MS Market Size by Type
7.2.1 Europe Clinical LC-MS Market Size by Type (2017-2022)
7.2.2 Europe Clinical LC-MS Market Size by Type (2023-2028)
7.2.3 Europe Clinical LC-MS Market Share by Type (2017-2028)
7.3 Europe Clinical LC-MS Market Size by Application
7.3.1 Europe Clinical LC-MS Market Size by Application (2017-2022)
7.3.2 Europe Clinical LC-MS Market Size by Application (2023-2028)
7.3.3 Europe Clinical LC-MS Market Share by Application (2017-2028)
7.4 Europe Clinical LC-MS Market Size by Country
7.4.1 Europe Clinical LC-MS Market Size by Country (2017-2022)
7.4.2 Europe Clinical LC-MS Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical LC-MS Market Size (2017-2028)
8.2 Asia-Pacific Clinical LC-MS Market Size by Type
8.2.1 Asia-Pacific Clinical LC-MS Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Clinical LC-MS Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Clinical LC-MS Market Share by Type (2017-2028)
8.3 Asia-Pacific Clinical LC-MS Market Size by Application
8.3.1 Asia-Pacific Clinical LC-MS Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Clinical LC-MS Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Clinical LC-MS Market Share by Application (2017-2028)
8.4 Asia-Pacific Clinical LC-MS Market Size by Region
8.4.1 Asia-Pacific Clinical LC-MS Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Clinical LC-MS Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Clinical LC-MS Market Size (2017-2028)
9.2 Latin America Clinical LC-MS Market Size by Type
9.2.1 Latin America Clinical LC-MS Market Size by Type (2017-2022)
9.2.2 Latin America Clinical LC-MS Market Size by Type (2023-2028)
9.2.3 Latin America Clinical LC-MS Market Share by Type (2017-2028)
9.3 Latin America Clinical LC-MS Market Size by Application
9.3.1 Latin America Clinical LC-MS Market Size by Application (2017-2022)
9.3.2 Latin America Clinical LC-MS Market Size by Application (2023-2028)
9.3.3 Latin America Clinical LC-MS Market Share by Application (2017-2028)
9.4 Latin America Clinical LC-MS Market Size by Country
9.4.1 Latin America Clinical LC-MS Market Size by Country (2017-2022)
9.4.2 Latin America Clinical LC-MS Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical LC-MS Market Size (2017-2028)
10.2 Middle East & Africa Clinical LC-MS Market Size by Type
10.2.1 Middle East & Africa Clinical LC-MS Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Clinical LC-MS Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Clinical LC-MS Market Share by Type (2017-2028)
10.3 Middle East & Africa Clinical LC-MS Market Size by Application
10.3.1 Middle East & Africa Clinical LC-MS Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Clinical LC-MS Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Clinical LC-MS Market Share by Application (2017-2028)
10.4 Middle East & Africa Clinical LC-MS Market Size by Country
10.4.1 Middle East & Africa Clinical LC-MS Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Clinical LC-MS Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Details
11.1.2 Danaher Business Overview
11.1.3 Danaher Clinical LC-MS Introduction
11.1.4 Danaher Revenue in Clinical LC-MS Business (2017-2022)
11.1.5 Danaher Recent Developments
11.2 Bruker
11.2.1 Bruker Company Details
11.2.2 Bruker Business Overview
11.2.3 Bruker Clinical LC-MS Introduction
11.2.4 Bruker Revenue in Clinical LC-MS Business (2017-2022)
11.2.5 Bruker Recent Developments
11.3 Agilent
11.3.1 Agilent Company Details
11.3.2 Agilent Business Overview
11.3.3 Agilent Clinical LC-MS Introduction
11.3.4 Agilent Revenue in Clinical LC-MS Business (2017-2022)
11.3.5 Agilent Recent Developments
11.4 Thermo Fisher
11.4.1 Thermo Fisher Company Details
11.4.2 Thermo Fisher Business Overview
11.4.3 Thermo Fisher Clinical LC-MS Introduction
11.4.4 Thermo Fisher Revenue in Clinical LC-MS Business (2017-2022)
11.4.5 Thermo Fisher Recent Developments
11.5 Waters
11.5.1 Waters Company Details
11.5.2 Waters Business Overview
11.5.3 Waters Clinical LC-MS Introduction
11.5.4 Waters Revenue in Clinical LC-MS Business (2017-2022)
11.5.5 Waters Recent Developments
11.6 Shidmazu
11.6.1 Shidmazu Company Details
11.6.2 Shidmazu Business Overview
11.6.3 Shidmazu Clinical LC-MS Introduction
11.6.4 Shidmazu Revenue in Clinical LC-MS Business (2017-2022)
11.6.5 Shidmazu Recent Developments
11.7 Perkin Elmer
11.7.1 Perkin Elmer Company Details
11.7.2 Perkin Elmer Business Overview
11.7.3 Perkin Elmer Clinical LC-MS Introduction
11.7.4 Perkin Elmer Revenue in Clinical LC-MS Business (2017-2022)
11.7.5 Perkin Elmer Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Clinical LC-MS Introduction
11.8.4 Merck Revenue in Clinical LC-MS Business (2017-2022)
11.8.5 Merck Recent Developments
11.9 BGI
11.9.1 BGI Company Details
11.9.2 BGI Business Overview
11.9.3 BGI Clinical LC-MS Introduction
11.9.4 BGI Revenue in Clinical LC-MS Business (2017-2022)
11.9.5 BGI Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer